Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
P2X7 Receptor as a Therapeutic Target.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.
Exercising Impacts on Fatigue, Depression, and Paresthesia in Female Patients with MS.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Effects of Tysabri over 12 months on multiple sclerosis (MS) related fatigue in patients with relapsing remitting multiple sclerosis (RRMS) (TYNERGY)
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
[Current and historical concept of neuromyelitis optica].
[Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives].
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
Control of microglial neurotoxicity by the fractalkine receptor.
Hilbert-Huang transform based instrumental assessment of intention tremor in multiple sclerosis.
How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System?
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Pages
« first
‹ previous
…
713
714
715
716
717
718
719
720
721
…
next ›
last »